Centers for Disease Control and Prevention
 CDC Home Search Health Topics A-Z


Division of Vector-Borne Infectious Diseases Dengue: Clinical Manifestations and Epidemiology

 
slide 6 of 9
 Back Menu Table of contents Next
 

Presence of DEN-3 in the Americas, 1994-2007

Presence of DEN-3 in the Americas, 1994-2007

One reason for the increase in dengue incidence seen in 1995 was the detection of the arrival and the transmission of DEN-3—which had not been in the Americas for 20 years. In 1994, DEN-3 was first detected in the southern part of Central America in Panama, Nicaragua and Costa Rica. By 1995, it had spread northward and was detected up to northern Mexico near the Texas border, in Guatemala, El Salvador, and Honduras. In 1997, DEN-3 was detected in Belize and Guyana, in 1998 it was detected in several Caribbean islands: Puerto Rico, Jamaica, the Dominican Republic (on the island of Hispaniola), Barbados, and St. Christopher/Nevis. In 1999 this serotype was detected in French Guiana and in 2000 in Cuba, and in Brazil. No cases of DENV 3 have been reported in Chile, Uruguay and Haiti as of 2007.

Esta página en Español

Back | Menu | Next |

CDC Home | Search | Health Topics A-Z |

This page last reviewedFebruary 8, 2008

Division of Vector-Borne Infectious Diseases |
National Center for Zoonotic, Vector-Borne, and Enteric Diseases (NCZVED) |
Centers for Disease Control and Prevention |
3150 Rampart Rd. Fort Collins, CO 80522

CDC Privacy Policy | Accessibility |